Clinical Trials Browser

Active not recruiting × Blood Specimen Collection × Clear all

NCT02453620 2026-03-18

Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 1 Active not recruiting

BreastOther solid neoplasm

Anatomic Stage III Breast Cancer AJCC v8

NCT02867033 2026-03-18

ALTITUDES

Phase NA Active not recruiting

Desmoid Tumors

NCT04454528 2026-03-10

BreastVAX

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT07421479 2026-02-19

PDO-Mercurial

Active not recruiting

Triple Negative Breast Neoplasms

NCT02531607 2026-02-05

Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC)

Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03424915 2026-02-04

Exercise, Fitness and Tumor Profiling in Breast Cancer Patients

Active not recruiting

Breast Neoplasms

NCT05415358 2026-02-03

Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients

Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03842696 2026-01-27

Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

Phase 1/2 Active not recruiting

LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Graft vs Host Disease, Hematologic Diseases, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT03875690 2026-01-20

CORTIFRENCH

Phase 3 Active not recruiting

Elective Surgery for Any Digestive Cancer

NCT03465618 2026-01-07

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

Phase 1 Active not recruiting

Brain Neoplasms, Pituitary Neoplasms

NCT03955978 2026-01-06

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

Phase 1 Active not recruiting

Endometrial Neoplasms

NCT01991379 2025-12-04

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1/2 Active not recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05165160 2025-12-03

LUNGDOC

Phase NA Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT03432806 2025-12-02

A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors

Active not recruiting

Gastrointestinal

Colonic Neoplasms, Carcinoma, Hepatocellular

NCT05874726 2025-12-02

Biological Sample Repository for Gastrointestinal Disorders

Active not recruiting

GastrointestinalOther

Collagen Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, Gastroesophageal Reflux, Hyperlipidemias, Hypertension, Neoplasms, Obesity, Obesity, Morbid, Sleep Apnea Syndromes, Weight Loss, Overweight

NCT04412629 2025-11-24

Cabozantinib in High Grade Neuroendocrine Neoplasms

Phase 2 Active not recruiting

High Grade Neuroendocrine Neoplasms

NCT03731845 2025-11-20

ESIGON

Phase NA Active not recruiting

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT04902833 2025-11-18

Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

Active not recruiting

Classical hematologyMyeloidOther hematologic neoplasm

Pyruvate Kinase Deficiency of Red Cells, Anemia, Hemolytic, Congenital, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases

NCT04968548 2025-11-04

Determination and Validation of a Multi-analyte Assay for Lung Cancer Screening

Active not recruiting

Lung Neoplasms

NCT04067726 2025-10-16

TRIDENT

Phase 2 Active not recruiting

Breast Neoplasms

NCT06594315 2025-09-18

Assessing Brain Metabolism Using MRS With Deuterated Glucose

Active not recruiting

Glioma

NCT01920737 2025-09-16

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia

NCT03739775 2025-09-15

CIRCA-HPV

Phase NA Active not recruiting

HPV Positive Pelvic Cancer

NCT05091190 2025-09-11

MADMAS

Phase NA Active not recruiting

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

NCT05011188 2025-08-27

FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT05020275 2025-08-15

RESISTYR

Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03776630 2025-08-12

GYNO-MIR

Phase NA Active not recruiting

Disease, Ovarian Neoplasms, Endometrial Neoplasms

NCT02743910 2025-07-17

Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer

Active not recruiting

Breast Neoplasms

NCT03996239 2025-07-17

Researching the Effect of Aerobic Exercise on Cancer

Phase NA Active not recruiting

Neoplasms

NCT04046575 2025-07-11

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

Phase 1 Active not recruiting

Gastrointestinal

Esophageal Neoplasms

NCT03984318 2025-06-26

PREMIS

Phase NA Active not recruiting

Neoplasms

NCT02597738 2025-06-19

A Feasibility Study to Further the Development of Lung Cancer-based Precision Medicine

Phase NA Active not recruiting

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT04785521 2025-06-11

Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery

Active not recruiting

Brain Neoplasms

NCT01953159 2025-06-08

Assessment of Paclitaxel-Induced Neuropathy

Active not recruiting

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00903591 2025-06-03

Study of Radiation Exposure and Bilateral Breast Cancer

Active not recruiting

Breast Neoplasms, Neoplasms

NCT04165564 2025-04-30

DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers

Active not recruiting

Lung Diseases

NCT02504697 2025-04-29

DECAMP-2

Active not recruiting

Lung Diseases

NCT04331067 2025-04-23

Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer

Phase 1/2 Active not recruiting

15 enrolled 12 charts

Triple Negative Breast Neoplasms

NCT02908048 2025-04-06

Extracellular RNA Markers of Liver Disease and Cancer

Active not recruiting

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

NCT03252717 2025-04-02

BIORISE

Phase NA Active not recruiting

Breast Neoplasms

NCT05953883 2025-03-04

PROGENITOR

Phase NA Active not recruiting

Ovarian Neoplasms

NCT06302660 2025-01-27

MAPLES

Active not recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06002945 2024-12-10

EXPLORE-MG2

Active not recruiting

Autoimmune Diseases, Immune System Diseases, Myasthenia Gravis, Nervous System Diseases, Muscle Weakness, Autoimmune Diseases of the Nervous System

NCT06597045 2024-09-19

BIOCAPRI

Active not recruiting

Neoplasms, Atherosclerosis, Cardiotoxicity

NCT03375437 2024-08-26

RNASARC

Phase NA Active not recruiting

Neoplasm Metastasis, Sarcoma

NCT02068196 2023-03-24

Ipi4

Phase 4 Active not recruiting

Melanoma, Neoplasms